We are live on
!
Find out more
Viking Therapeutics
VKTX
VKTX
140 hedge funds and large institutions have $166M invested in Viking Therapeutics in 2021 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 38 increasing their positions, 37 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
235% more call options, than puts
Call options by funds: $3.13M | Put options by funds: $933K
28% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 25
4% more funds holding
Funds holding: 134 → 140 (+6)
3% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 37
2.03% less ownership
Funds ownership: 48.3% → 46.27% (-2%)
30% less capital invested
Capital invested by funds: $238M → $166M (-$71.4M)
Holders
140
Holders Change
+6
Holders Change %
+4.48%
% of All Funds
2.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
32
Increased
38
Reduced
37
Closed
25
Calls
$3.13M
Puts
$933K
Net Calls
+$2.2M
Net Calls Change
-$5.22M
Top Buyers
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.66M |
| 2 |
Renaissance Technologies
New York
|
+$1.36M |
| 3 |
Millennium Management
New York
|
+$821K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$779K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$591K |
